Correspondence on 'Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding' by DeLoughery et al

BMJ Sex Reprod Health. 2024 Jan 9;50(1):71. doi: 10.1136/bmjsrh-2023-202053.
No abstract available

Keywords: Patient Advocacy; Patient Rights; Patient Satisfaction; Reproductive Health; research design.

Publication types

  • Letter

MeSH terms

  • Female
  • Humans
  • Menorrhagia* / diagnosis
  • Menstrual Hygiene Products
  • Norethindrone
  • Progesterone

Substances

  • Norethindrone
  • Progesterone